Other languages Devyser Diagnostics AB

Equities

DVYSR

SE0016588867

Delayed Nasdaq Stockholm Other stock markets 06:35:54 2024-05-08 am EDT			5-day change	1st Jan Change
99 ^SEK	+5.77%		-0.40%	+25.95%

09:00am	Transcript : Devyser Diagnostics AB, Q1 2024 Earnings Call, May 08, 2024
Apr. 25	Devyser Receives IVDR Approval for Post-Transplant Monitoring Software	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Devyser Receives IVDR Approval for Post-Transplant Monitoring Software	Apr. 25
Devyser Diagnostics AB Enters into Co-Marketing Agreement with Hamilton Bonaduz AG	Apr. 23
Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test	Mar. 11
Devyser Diagnostics AB Announces Study Publication Demonstrating dd-cfDNA Detection in Dual Donor Kidney Transplant Patient	Feb. 29
Devyser Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20
Devyser Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 19
Devyser Diagnostics AB Announces Michael Uhlin, CSO Joins Management Team as of February 1, 2024	Jan. 29
Devyser's US Lab Inks SEK25 Million Deal with UK Diagnostics Company Cyted	Jan. 17
Devyser Genomic Laboratories Signs First Commercial Agreement with Cyted	Jan. 17
Sweden’s Devyser Wins SEK1.5 Million Tender in Italy for Cystic Fibrosis Test Kits	Jan. 15
Devyser Diagnostics AB Wins Tender for Cystic Fibrosis in Italy	Jan. 15
Devyser Diagnostics Teams Up with Illumina to Offer IVD Tests in Europe, US	Jan. 08
Devyser Diagnostics AB Signs in Vitro Diagnostic Agreement with Illumina to Broaden Access to Its Tests	Jan. 08
Sweden’s Devyser Wins $6 Million Tender for Cystic Fibrosis Diagnostic Tool in Italy	Dec. 11
Devyser Wins Approximately SEK 2 Million Tender for Cystic Fibrosis	Dec. 11
Devyser Diagnostics Bags Non-invasive Fetal RHD Test Tender in Wales	Dec. 05
Devyser wins tender for non-invasive fetal RHD testing in Wales	Dec. 05
Devyser Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Devyser and Thermo Fisher Scientific Collaborate to Promote Laboratory Services to Advance Pharmaceutical Research	23-09-13
Thermo Fisher Scientific to Sell Devyser Diagnostics' Transplantation Products in Brazil	23-09-06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Devyser Diagnostics AB

Equities

DVYSR

SE0016588867

Other languages

Filters